EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Interferon Regulatory Factor 3 as a Mediator and Therapeutic Target in Innate Immune-Driven Corneal Stromal Inflammation and Opacity

Seung Hyeun Lee, Soo Jin Lee, Young In Yun, Ahra Koh, Hyunyoung Song, Yunjin Lee, Chang Ho Yoon, Ki Hean Kim, Kyoung Woo Kim

Investigative Ophthalmology & Visual Science · 2026

DOI: 10.1167/iovs.67.3.49 ↗

At a glance

Journal article in Investigative Ophthalmology & Visual Science, 2026. Written by Seung Hyeun Lee and 8 co-authors. Institution: Department of Ophthalmology, Chung-Ang University College of Medicine, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong-si, Republic of Korea. Major MEDLINE topics: Interferon Regulatory Factor-3, Corneal Stroma, Immunity, Innate, Corneal Opacity. 51 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Purpose

Interferon regulatory factor 3 (IRF3) is classically recognized for antiviral immunity, yet emerging evidence implicates it in sterile inflammation. This study investigated whether IRF3 regulates macrophage-stromal signaling driving corneal pathology and evaluated the therapeutic potential of targeting IRF3.

Methods

In vitro assays utilized human macrophages stimulated with lipopolysaccharide (LPS) and interferon-γ (IFNγ) to generate an inflammatory macrophage population (Mϕ-LPS/IFNγ cells), along with primary human corneal stromal fibroblasts (HCFs) stimulated with LPS. IRF3 was silenced by small interfering RNA (siRNA), and inflammatory mediators and toll-like receptor 4 (TLR4)/MyD88 transcripts were quantified. Macrophage-HCF interactions were assessed in Transwell cocultures. In vivo, Irf3-/- and wild-type mice underwent corneal epithelial debridement followed by topical LPS to evaluate corneal opacity, fibrotic markers, cytokine expression, and myeloid-cell subsets. Piceatannol, a stilbenoid compound known to inhibit IRF3, was tested in vitro and as topical eye drops.

Results

IRF3 expression was upregulated in both macrophages and HCFs under inflammatory conditions. Silencing IRF3 significantly reduced inflammatory cytokines, including CXCL10, and decreased TLR4-associated transcripts in HCFs. In cocultures, IRF3-silenced macrophages partially attenuated HCF activation. In vivo, Irf3 deficiency markedly reduced LPS-induced corneal opacity, stromal inflammatory transcripts, monocyte recruitment, and macrophage-associated markers. Piceatannol suppressed IRF3-dependent inflammatory responses in vitro and, when applied topically, reduced corneal Irf3 expression and myeloid/inflammatory signatures.

Conclusions

IRF3 is a pivotal regulator of innate immune-driven stromal inflammation and opacity. Both genetic and pharmacologic inhibition of IRF3 attenuated cytokine and myeloid responses, suggesting that targeting IRF3, potentially via piceatannol (PIC), offers a therapeutic strategy for preserving corneal transparency.

Subjects

MeSH terms (MEDLINE)

Interferon Regulatory Factor-3Corneal StromaImmunity, InnateCorneal OpacityGene Expression RegulationKeratitisAnimalsMiceHumansMice, Inbred C57BLMacrophagesCells, CulturedDisease Models, AnimalMice, KnockoutCoculture TechniquesCytokines

Substances

Interferon Regulatory Factor-3Irf3 protein, mouseCytokines

Authors and institutions

  • Department of Ophthalmology, Chung-Ang University College of Medicine, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong-si, Republic of Korea.
  • Chung-Ang Ocular Surface Restoration through Immune Regulation and Inflammation Attenuation (CORIA) Laboratory, Seoul, Republic of Korea.
  • Chung-Ang University Graduate School, Seoul, Republic of Korea.
  • Department of Ophthalmology, Dongguk University Ilsan Hospital, Goyang-si, Republic of Korea.
  • Department of Ophthalmology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Department of Ophthalmology, Gachon University College of Medicine, Gil Medical Center, Incheon, Republic of Korea.

Cite

APA

Lee, S. H., Lee, S. J., Yun, Y. I., Koh, A., Song, H., Lee, Y., Yoon, C. H., Kim, K. H., & Kim, K. W. (2026). Interferon Regulatory Factor 3 as a Mediator and Therapeutic Target in Innate Immune-Driven Corneal Stromal Inflammation and Opacity. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.3.49

Vancouver

Lee SH, Lee SJ, Yun YI, Koh A, Song H, Lee Y, et al. Interferon Regulatory Factor 3 as a Mediator and Therapeutic Target in Innate Immune-Driven Corneal Stromal Inflammation and Opacity. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.3.49

BibTeX
@article{Lee2026,
  author = {Lee, Seung Hyeun and Lee, Soo Jin and Yun, Young In and Koh, Ahra and Song, Hyunyoung and Lee, Yunjin and Yoon, Chang Ho and Kim, Ki Hean and Kim, Kyoung Woo},
  title = {Interferon Regulatory Factor 3 as a Mediator and Therapeutic Target in Innate Immune-Driven Corneal Stromal Inflammation and Opacity},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2026},
  doi = {10.1167/iovs.67.3.49}
}
Start for free →